Becton Dickinson Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BECTON DICKINSON, and what generic alternatives to BECTON DICKINSON drugs are available?
BECTON DICKINSON has seven approved drugs.
There are two US patents protecting BECTON DICKINSON drugs.
There are twenty patent family members on BECTON DICKINSON drugs in twelve countries.
Summary for Becton Dickinson
International Patents: | 20 |
US Patents: | 2 |
Tradenames: | 10 |
Ingredients: | 4 |
NDAs: | 7 |
Drugs and US Patents for Becton Dickinson
Expired US Patents for Becton Dickinson
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Becton Dickinson Co | CHLORAPREP ONE-STEP SEPP | chlorhexidine gluconate; isopropyl alcohol | SWAB;TOPICAL | 021555-001 | Oct 7, 2002 | 5,690,958 | ⤷ Subscribe |
Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-002 | May 3, 2005 | 6,991,394 | ⤷ Subscribe |
Becton Dickinson Co | CHLORAPREP WITH TINT | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-007 | Oct 10, 2006 | 7,241,065 | ⤷ Subscribe |
Becton Dickinson Co | CHLORAPREP SINGLE SWABSTICK | chlorhexidine gluconate; isopropyl alcohol | SWAB;TOPICAL | 021555-002 | May 10, 2005 | 5,690,958 | ⤷ Subscribe |
Becton Dickinson Co | CHLORAPREP ONE-STEP | chlorhexidine gluconate; isopropyl alcohol | SPONGE;TOPICAL | 020832-006 | Nov 21, 2006 | 5,690,958 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Becton Dickinson Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 1581300 | ⤷ Subscribe |
Mexico | PA05007458 | ⤷ Subscribe |
Canada | 2512593 | ⤷ Subscribe |
Canada | 2519176 | ⤷ Subscribe |
Japan | 5019711 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.